Skip to content

Insider · CIK 0001702957

Jeffrey Lawrence Schwartz

directorowner

Files at KMTS (KESTRA MEDICAL TECHNOLOGIES, LTD.). First filing Sep 10, 2026, latest Sep 10, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $98k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

KMTS: KESTRA MEDICAL TECHNOLOGIES, LTD.

KMTSOct 9, 2026 · close 26.98

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
50Moderate
KMTSsell 5
KESTRA MEDICAL TECHNOLOGIES, LTD.
$98k
3,890 shares
-36%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 8, 2026KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
SOpen-market sale
Common Shares
-3,890$25.18$98k7,01932 d ago
Sep 9, 2026KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
AGrant or award
Common Shares
+7,217--14,23632 d ago
Sep 4, 2025KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
AGrant or award
Common Shares
+10,909--10,909Sep 8, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jeffrey Lawrence Schwartz: insider trades and track record | InsiderTell